Full name
DOBRY LEK SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
32.99.Z - Production of other products not classified elsewhere
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -2,5 | 4,5 | -22 | -590,3 |
Gross profit (loss) | -2,5 | 4,5 | -22 | -591,2 |
EBITDA | -2,5 | 4,5 | -22 | -590,3 |
Short time liabilities | 13,4 | 5 | 30,9 | 519,3 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | -7,7 | 4,4 | -17,6 | -500,3 |
Operating profit (EBIT) | -2,5 | 4,5 | -22 | -590,3 |
Assets | 5,8 | 9,4 | 13,3 | 41,8 |
Net profit (loss) | -2,6 | 4,1 | -22 | -639,9 |
Cash | 5,8 | 9,4 | 13 | 38,4 |
Net income from sale | 109 | 175 | 197 | 12,6 |
Liabilities and provisions for liabilities | 13,4 | 5 | 30,9 | 519,3 |
Working assets | 5,8 | 9,4 | 13,3 | 41,8 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 33,4 | 92,7 | 125 | 32,3 |
Equity capital to total assets | -133,5 | 46,8 | -132,2 | -179 |
Gross profit margin | -2,3 | 2,6 | -11,2 | -13,8 |
EBITDA Margin | -2,3 | 2,6 | -11,2 | -13,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 45 | 10 | 57 | 47 |
Current financial liquidity indicator | 0.4282163977622986 | 1.880957841873169 | 0.4306022822856903 | -1,5 |
Net dept to EBITDA | -1.1918487548828125 | -2.002800703048706 | 0.572490930557251 | 2,6 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane